ADVANZ
Live / Applied — Third extension granted (statement of use) (as of 08 Jan 2026)
What this means for you
Not registered yet, but its 10 Nov 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97671247
- Mark type
- Stylized text
- Filed
- 10 Nov 2022
- Published for opposition
- 14 May 2024
- Attorney of record
- Caroline Duncan
Goods and services
- Class 005 — Pharmaceuticals: A full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines and immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells; all of the foregoing excluding pharmaceutical preparations acting on the peripheral or central nervous system, surgical kits comprised of medical and surgical apparatus and instruments, and surgical implants comprised of human and animal tissue; all of the foregoing excluding anti-infective pharmaceutical preparations
- Class 010 — Medical apparatus: Medical devices, namely, lasers and fibre-optic wires and cables for use in photodynamic therapy with the administration of a photosensitizing agent for the treatment of cancer
Owner
- Mercury Pharma Group Limited, London, GB
- Mercury Pharma Group Limited, London, GB
Prosecution history
- 09 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jan 2026 — SOU EXTENSION 3 GRANTED
- 08 Jan 2026 — SOU EXTENSION 3 FILED
- 08 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 05 Jan 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 05 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 10 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jul 2025 — SOU EXTENSION 2 GRANTED
- 09 Jul 2025 — SOU EXTENSION 2 FILED
- 09 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jan 2025 — SOU EXTENSION 1 GRANTED
- 09 Jan 2025 — SOU EXTENSION 1 FILED